Ovarian Fragmentation Study (Crespo Medical Team)
Launched by EQUIPO JUANA CRESPO · Mar 10, 2020
Trial Information
Current as of June 26, 2025
Unknown status
Keywords
ClinConnect Summary
No description provided
Gender
FEMALE
Eligibility criteria
- Inclusion Criteria:
- • Abdominal surgery need for fertility cause.
- * Bad embryo quality (\>2 cycles with \< 1 embryo A-B quality. With:
- • A. Poor ovarian responders (previous ≤ 3 retrieved metaphase II oocytes) in a conventional cycle.
- • B. Decreased ovarian reserve (antral follicle count (AFC) ≤ 5 or antiMullerian hormone (AMH) ≤ 0.5 ng/mL).
- C.Premature ovarian insufficiency according to:
- • Patients \< 40 years old.
- • At least 1 year of amenorrhea.
- • Follitropin serum levels (FSH) \>35 IU/ml in two serum samples separated by at least 1 month.
- • Estradiol serum levels (E2) \< 20 pg/mL.
- Exclusion Criteria:
- • 1. Clinical/ultrasonographical signs of severe endometriosis ( or endometrioma).
- • 2. Age over 45 years (EMC)
- • 3. Previous ovarian/pelvic surgery. Unilateral oophorectomy.
- • 4. Body Mass Index \> 30
- • 5. Previous gonadotoxic treatment.
- • 6. Genito-urinary tract malformations.
- • 7. Inform consent unsigned.
About Equipo Juana Crespo
Equipo Juana Crespo is a dedicated clinical trial sponsor committed to advancing medical research and improving patient outcomes. With a focus on innovative therapeutic solutions, the organization collaborates with leading healthcare professionals and research institutions to design and conduct robust clinical trials. By adhering to the highest ethical standards and regulatory guidelines, Equipo Juana Crespo ensures the integrity of its research while prioritizing patient safety and well-being. Their expertise spans a range of therapeutic areas, making them a pivotal player in the landscape of clinical development.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Valencia, , Spain
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials